The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

Share Price Information for Science Sprt (SIS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.75
Bid: 15.50
Ask: 16.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.226%)
Open: 15.75
High: 15.75
Low: 15.75
Prev. Close: 15.75
SIS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Close Trading Update

22 Feb 2023 07:00

RNS Number : 6228Q
Science in Sport PLC
22 February 2023
 

Science in Sport plc

("Science in Sport", "the Company" or the "Group")

 

Pre-Close Trading Update

 

Science in Sport, the premium performance nutrition company serving elite athletes, sports enthusiasts, and the active lifestyle community, is pleased to announce a pre-close trading update for the financial year ended 31 December 2022.

Trading

 

Against the tough economic and supply chain environment throughout the year, the Group performed broadly in-line with expectations. Group revenue growth of 1.5% to £63.5m (FY2021: £62.7m) was achieved.

 

A stronger margin performance in H2 due to the new Blackburn site delivering significant logistics efficiencies, coupled with the delivery of sustainable cost savings across the business, delivered margins in line with expectations. This world-class asset is planned to be the bedrock of further improvements and strategic advantage in the global sports nutrition sector from 2023 onwards.

 

Operational Developments

 

We have executed a wide-ranging restructuring of the business, including strategic investment, setting ourselves up for success in 2023 and beyond -

 

· A state-of-the-art protein bar line has been commissioned this month in Blackburn and is fully operational. This asset eliminates proposed substantial 2023 co-manufacturing cost increases and will contribute significantly to profitability. In addition to a transformation in margin, the new line underpins major innovation projects which are expected to deliver incremental revenue in 2023.

· Our USA business this month transferred to The Feed, the leading online distributor of endurance nutrition brands in the region. As well as accessing our core consumer market, the deal results in a strong improvement in expected cash generation for 2023.

· A strategic partnership has been agreed for our already strong Marketplace business with Flywheel Digital, the global leader in Amazon growth delivery. 2023 sales to consumer are showing good growth, and we expect to see outperformance from March because of the new partnership.

· People costs for 2022 were significantly under budget and we expect to hold this cost flat in 2023, despite wage inflation. 2023 will also see a solid reduction in overheads versus 2022. Capital expenditure will be at an all-time low, given we have exited the strategic investment phase in supply chain and technology.

 

Outlook

 

Management is optimistic about the prospects for 2023. Macro factors including COVID-19 in China and Amazon global inventory reduction are alleviating. Retail in all regions is in line with our expectations for growth, and the UK had a strong start to the year. Margins are strongly improved due to initiatives including the above items, and a second wave of price increases beginning to contribute.

For further information:

 

Science in Sport plc

T: 020 7400 3700

Stephen Moon, CEO

Daniel Lampard, CFO

 

Liberum (Nominated Adviser and Broker)

T: 020 3100 2000

Richard Lindley

William Hall

Lucas Bamber

 

 

Notes to Editors:

 

About Science in Sport plc

 

Headquartered in London, Science in Sport plc is a leading sports nutrition business that develops, manufactures, and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the active lifestyle community. The Company has two highly regarded brands, PhD Nutrition, a premium active-nutrition brand targeting the active lifestyle community, and SiS, a leading endurance nutrition brand among elite athletes and professional sports teams.

 

The two brands sell through the Company's phd.com and scienceinsport.com digital platforms, third-party online sites, including Amazon and Tmall, and extensive retail distribution in the UK and internationally, including major supermarkets, high street chains and specialist sports retailers. This omnichannel footprint enables the Company to address the full breadth of the sports nutrition market, worth $42.9bn in 2022 and forecast to grow CAGR 7.4% from 2023 to 2030.1

 

PhD is one of the UK's leading active nutrition brands with a reputation for high quality and product innovation. The brand has grown rapidly since its launch in 2005. The range now comprises powders, bars, and supplements, including the high protein, low sugar range, PhD Smart. PhD brand ambassadors include leading endurance and strength athlete Ross Edgley and influencer Gabby Allen. 

 

SiS, a leading endurance nutrition business founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration, and recovery. SiS is an official endurance nutrition supplier to over 320 professional teams, organisations, and national teams worldwide. SiS supplies more than 150 professional football clubs in the UK, Europe, and the USA.

 

SiS is Performance Solutions partner to Ineos Grenadiers cycling team, and Tottenham Hotspur and CGC Nice football clubs, as well as Official Nutrition Partner to the Milwaukee Bucks, 2021 National Basketball Association Champions. We provide our Performance Solutions service to Gotytom Gebreslase, the World Champion women's marathon runner.

 

For further information, please visit phd.com and scienceinsport.com

 

Grand View Research (2022)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSDFEILFIV
Date   Source Headline
6th Mar 20247:00 amRNSTrading Update
5th Jan 20247:00 amRNSDirector/PDMR Shareholding
5th Jan 20247:00 amRNSNotification of Major Holdings
29th Dec 202311:20 amRNSIssue of Equity and Total Voting Rights
19th Oct 20237:00 amRNSDirectorate Change
16th Oct 20237:00 amRNSBoard Changes
28th Sep 202310:30 amRNSInterim Results - Replacement
28th Sep 20237:00 amRNSAppointment of Non Exec Chairman
28th Sep 20237:00 amRNSInterim Results
28th Jul 20232:58 pmRNSResult of Annual General Meeting
28th Jul 20237:00 amRNSBoard changes
10th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20233:49 pmRNSTR-1: Notification of Major Holdings
5th Jul 20237:00 amRNSBoard Change and Notice of AGM
4th Jul 20237:30 amRNSRestoration - Science in Sport PLC
4th Jul 20237:00 amRNSRestoration of Trading & Posting of Annual Report
3rd Jul 20237:30 amRNSSuspension - Science In Sport Plc
3rd Jul 20237:00 amRNSTemporary Suspension
29th Jun 202310:38 amRNSReplacement RNS - Preliminary Results
29th Jun 20237:00 amRNSFinal results
28th Jun 202310:43 amRNSNotification of Major Holdings
23rd Jun 20237:00 amRNSNotice of Final Results
2nd May 20233:33 pmRNSAIM Rule 17 / Schedule 2(g) Update
18th Apr 20237:00 amRNSInvestor Site Visit
13th Apr 202312:23 pmRNSForm 8.3 - Science In Sport Plc
13th Apr 202312:06 pmRNSForm 8.3 - Science in Sport PLC
13th Apr 20238:34 amRNSForm 8.5 (EPT/RI)
13th Apr 20237:00 amRNSConclusion of Strategic Review and Trading Update
12th Apr 20239:06 amRNSForm 8.5 (EPT/RI)
11th Apr 20232:54 pmRNSForm 8.3 - Science In Sport Plc
11th Apr 202312:17 pmRNSForm 8.3 - Science in Sport PLC
11th Apr 20239:22 amRNSForm 8.5 (EPT/RI)
11th Apr 20237:00 amRNSForm 8.3 - Science in Sport PLC
6th Apr 20236:17 pmRNSForm 8.3 - SCIENCE IN SPORT PLC
6th Apr 20232:52 pmRNSForm 8.3 - [Science in Sport plc]
5th Apr 20238:22 amRNSForm 8.5 (EPT/RI)
3rd Apr 20232:29 pmRNSForm 8.3 - [Science in Sport plc]
3rd Apr 20239:20 amRNSForm 8.5 (EPT/RI)
30th Mar 20238:50 amRNSForm 8.5 (EPT/RI)
29th Mar 202311:58 amRNSForm 8.3 - Science in Sport Plc
29th Mar 20238:42 amRNSForm 8.5 (EPT/RI)
28th Mar 20239:57 amRNSForm 8.3 - Science in Sport Plc
28th Mar 20239:52 amRNSForm 8.5 (EPT/RI) - Science in Sport PLC
27th Mar 202312:31 pmRNSForm 8.3 - Science in Sport PLC
27th Mar 202312:29 pmRNSForm 8.3 - Science in Sport Plc
23rd Mar 202311:01 amRNSForm 8.3 - Science in Sport PLC
23rd Mar 202310:54 amRNSForm 8.3 - Science in Sport PLC
23rd Mar 20238:43 amRNSForm 8.5 (EPT/RI)
22nd Mar 20235:55 pmRNSForm 8.3 - Science in Sport PLC
22nd Mar 20231:15 pmRNSForm 8.3 - Science in Sport plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.